FAKTOR OPTIONSSCHEIN - EMERGENT BIOSOLUTIONS Share Price

Certificat

DE000GG7S3C1

Real-time BOERSE MUENCHEN 15:25:59 01/07/2024 BST
1.548 EUR +0.85% Intraday chart for FAKTOR OPTIONSSCHEIN - EMERGENT BIOSOLUTIONS
Current month-47.61%
1 month-67.13%
Date Price Change
01/07/24 1.548 +0.85%
28/06/24 1.535 -1.98%
27/06/24 1.566 -12.71%
26/06/24 1.794 +10.60%
25/06/24 1.622 -7.74%

Real-time BOERSE MUENCHEN

Last update July 01, 2024 at 03:25 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying EMERGENT BIOSOLUTIONS INC.
Issuer Goldman Sachs
WKN GG7S3C
ISINDE000GG7S3C1
Date issued 07/05/2024
Strike 10.23 $
Maturity Unlimited
Parity 1.98 : 1
Emission price 8.81
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 7.36
Lowest since issue 1.476
Spread 0.01
Spread %0.63%

Company Profile

Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a Bioservices portfolio. Its segments include Commercial Products, MCM Products, and Services Segment. Commercial Products segment include NARCAN (naloxone HCl). MCM Products segment consists of its Anthrax - MCM, Smallpox - MCM and Other Products. Services segment consisting of its Bioservices offerings. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression. Its portfolio of Bioservices consists of three but interrelated service pillars, such as development services (process and analytical development) and drug substance manufacturing.
Sector
-
More about the company

Ratings for Emergent BioSolutions Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Emergent BioSolutions Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
6.82 USD
Average target price
8 USD
Spread / Average Target
+17.30%
Consensus